Valuation: Ainos, Inc.

Market Cap 9.79M 8.61M 8.02M 7.36M 13.82M 939M 14M 95.27M 37.21M 464M 36.77M 35.98M 1.6B P/E 2024
-0.29x
P/E 2025 -0.47x
Enterprise Value 20.38M 17.91M 16.68M 15.31M 28.76M 1.95B 29.14M 198M 77.41M 965M 76.5M 74.85M 3.34B EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
33.62%
Yield 2024 *
-
Yield 2025 -
1 day-5.00%
1 week-16.35%
Current month-31.44%
1 month-23.12%
3 months-27.72%
6 months-22.67%
Current year-18.90%
1 week 1.32
Extreme 1.32
1.62
1 month 1.32
Extreme 1.32
2.31
Current year 1.26
Extreme 1.26
3.88
1 year 1.26
Extreme 1.26
4.5
3 years 1.26
Extreme 1.26
25.5
5 years 1.26
Extreme 1.26
450
10 years 1.26
Extreme 1.26
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 2021-04-14
Director of Finance/CFO 54 2024-03-14
Director TitleAgeSince
Director/Board Member 49 2021-04-14
Director/Board Member 54 2021-04-14
Director/Board Member 42 2021-04-14
Date Insider Type Main position Quantity % Market Cap.
6/5/26 Buy

Director

3,500 0.0501%
6/3/26 Buy

Director

2,000 0.0286%
5/28/26 Buy

Director

250 0.0036%
Change 5-day change 1-year change 3-year change Capi.($)
-5.00%-16.35%-48.45%-94.52% 10.31M
-1.54%+6.33%+16.98%-0.09% 211B
+2.61%-2.29%-4.37%-23.02% 135B
+5.73%+1.04%-28.04%+10.28% 119B
+2.85%+3.98%-57.12%-13.54% 65.77B
+0.50%-2.31%+3.80%+0.45% 47.58B
+1.43%+0.59%-25.87%-33.53% 44.44B
-0.49%+5.86%+14.74%+8.87% 39.14B
-0.93%+3.82%+22.53%+30.15% 36.79B
-2.38%+2.59%+73.35%-0.12% 29.37B
Average +0.28%-0.54%-3.25%-11.51% 72.81B
Weighted average by Cap. +1.18%+1.55%-2.08%-3.85%

Financials

2024 2025
Net sales 20.73K 18.22K 16.96K 15.58K 29.25K 1.99M 29.64K 202K 78.75K 982K 77.81K 76.14K 3.39M 124K 109K 102K 93.31K 175K 11.91M 178K 1.21M 472K 5.88M 466K 456K 20.32M
Net income -14.86M -13.07M -12.16M -11.17M -20.97M -1.43B -21.25M -145M -56.47M -704M -55.79M -54.59M -2.43B -14.77M -12.99M -12.09M -11.1M -20.84M -1.42B -21.12M -144M -56.12M -699M -55.45M -54.25M -2.42B
Net Debt 8.11M 7.13M 6.63M 6.09M 11.44M 777M 11.59M 78.86M 30.8M 384M 30.43M 29.78M 1.33B 10.58M 9.3M 8.66M 7.95M 14.93M 1.01B 15.13M 103M 40.2M 501M 39.73M 38.87M 1.73B
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
26-07-27 US$1.330 -5.00% 58,756
26-07-24 US$1.400 -7.28% 39,461
26-07-23 US$1.510 -1.95% 14,673
26-07-22 US$1.540 -1.28% 19,450
26-07-21 US$1.560 -1.89% 36,572
  1. Stock Market
  2. Stocks
  3. AIMD Stock